Product image of Levosert Easy (Levonorgestrel) supplied by GNH India

Levosert Easy

Active Ingredient:
Levonorgestrel
Origin:
EU

Levosert Easy (Levonorgestrel)

Levonorgestrel, the active ingredient in Levosert Easy, is a progestogen presented as an intrauterine system for intrauterine use. It provides long‑acting reversible contraception and can also be used to manage heavy menstrual bleeding in women of reproductive age.

GNH India supplies Levosert Easy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is manufactured under strict quality controls, and our distribution network ensures timely delivery and regulatory compliance for each shipment.

Manufacturer / TM Owner

Gedeon Richter Polska Sp. Z. O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levonorgestrel delivered via an intrauterine system acts on the reproductive hormonal pathway to provide contraception and related therapeutic benefits.
  • Contraception: Provides highly effective, long‑acting reversible contraception for women of reproductive age.
  • Heavy menstrual bleeding: Reduces menstrual blood loss and improves bleeding patterns in women with menorrhagia.
  • Endometrial protection: Induces endometrial atrophy, decreasing the risk of hyperplasia during estrogen therapy.

How It Works

  • Levonorgestrel released from the intrauterine system binds to progesterone receptors in the endometrium and cervical mucus glands. This binding suppresses the mid‑cycle luteinizing hormone surge, thereby inhibiting ovulation, thickens cervical mucus to impede sperm passage, and induces endometrial atrophy, creating an environment unsuitable for implantation.

Side Effects

Levosert Easy may be associated with a range of local and systemic adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

  • Irregular vaginal bleeding or spotting
  • Amenorrhea (absence of periods)
  • Pelvic or abdominal pain
  • Headache
  • Breast tenderness
  • Acne or skin changes

Serious or Rare Side Effects

  • Uterine perforation during insertion
  • Device expulsion or displacement
  • Pelvic inflammatory infection
  • Ectopic pregnancy if contraception fails
  • Severe allergic reaction (anaphylaxis)
  • Ovarian cyst formation

Precautions & Warnings

  • Before insertion of Levosert Easy, clinicians should observe several precautionary measures to ensure safety and optimal efficacy.
  • Pregnancy testing: Confirm the patient is not pregnant prior to device placement.
  • Uterine abnormalities screening: Perform ultrasound to rule out fibroids, septa, or other structural issues.
  • Infection risk: Insert under aseptic conditions and treat any active pelvic infection before placement.
  • Hormone‑sensitive conditions: Avoid use in women with known or suspected breast cancer or other hormone‑dependent tumors.
  • Breastfeeding: Discuss benefits and risks with lactating patients; use with caution.
  • Store at ambient temperature: Keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel released from an intrauterine system can interact with other medicines that affect hormone metabolism or immune response.

Major Interactions (Avoid)

  • Enzyme inducers (e.g., rifampicin, carbamazepine): may reduce levonorgestrel efficacy.
  • Antifungal azoles (e.g., ketoconazole): may increase systemic exposure.
  • Protease inhibitors (e.g., ritonavir): may alter hormone levels.

Moderate Interactions (Monitor Closely)

  • Broad‑spectrum antibiotics (e.g., tetracycline): may modestly affect contraceptive effectiveness.
  • Certain anticonvulsants (e.g., phenytoin): may lower hormone concentrations.
  • Herbal supplements (e.g., St. John’s wort): may decrease contraceptive reliability.

Frequently Asked Questions

Levosert Easy is an intrauterine system that releases levonorgestrel for long‑acting reversible contraception. It is also indicated to reduce heavy menstrual bleeding and to provide endometrial protection in women who require hormonal therapy.

Levonorgestrel binds to progesterone receptors in the uterus, suppressing ovulation by inhibiting the luteinizing hormone surge, thickening cervical mucus to block sperm, and inducing endometrial atrophy, which together prevent fertilisation and implantation.

The dose is pre‑determined by the device design; a trained prescriber selects the appropriate Levosert Easy model, which releases a fixed amount of levonorgestrel over several years. Specific dosing regimens are set by the prescribing clinician.

Levosert Easy is contraindicated in pregnancy (Category X) and must not be inserted in a pregnant woman. For breastfeeding, the device can be used, but clinicians should discuss potential hormonal effects with the mother and monitor infant health.

Enquiries are submitted via the product page at gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levosert Easy is comparable to other levonorgestrel‑releasing IUS such as Mirena, offering similar efficacy and duration. Differences may lie in device size, release rate, and regulatory approvals in specific markets, but the core hormonal mechanism and safety profile are alike.

Store the device at ambient temperature, below 25 °C, in its original sealed packaging. Protect it from moisture, direct sunlight and physical damage. Handling should be performed by qualified healthcare professionals using aseptic technique during insertion.

Levosert Easy is inserted into the uterine cavity by a trained clinician using a specialized inserter. The procedure is performed in a clinical setting under sterile conditions, typically after confirming the patient is not pregnant and has no active pelvic infection.

Serious risks include uterine perforation during insertion, device expulsion or displacement, pelvic inflammatory infection, ectopic pregnancy if contraceptive failure occurs, and severe allergic reactions. Prompt medical evaluation is required if any of these events are suspected.

Women who are pregnant, have active pelvic infection, known or suspected breast cancer, unexplained vaginal bleeding, uterine anomalies (e.g., large fibroids, septate uterus), or are allergic to levonorgestrel or device components should avoid using Levosert Easy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT